REGN vs ROG · P/E 14, rev $14.34B vs P/E 82, rev $830.1M
Regeneron Pharmaceuticals Inc (REGN) versus Rogers Corporation (ROG) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Rogers Corporation (ROG) is a electronic components company listed on US.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported ROG revenue for 2024-12-31 was $830.1M. Net income was $26.1M. Revenue was down 8.6% from 2023-12-31 to 2024-12-31. ROG currently screens at market cap $1.36B and trailing P/E 81.6.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. ROG currently screens at market cap $1.36B and trailing P/E 81.6.
Not investment advice. Open the REGN and ROG stock pages for the full models.
Not investment advice.